Note: this series will no longer be updated. For the latest developments in these markets, please refer to the Interventional Cardiology DevicePeripheral Vascular Device, and Deep Venous Disease Treatment Device series.

The Asia Pacific market for clot management devices consists of a mixture of quickly expanding and relatively mature market segments, encompassing a wide variety of products used in the treatment of AV access thrombosis, PADVTECAD, and AIS.

This Medtech 360 Report provides high-level market metrics for clot management devices in Asia Pacific, including country-level data for major countries and aggregate data for the rest of the Asia Pacific Region, across a 10-year period.

Table of contents

  • Asia Pacific (Supplemental)
    • Abstract
    • Version History
    • Key Report Updates
    • Clot Management Device Market
      • Market Definitions
        • Market Definitions
        • Geographies Covered
        • Procedures Covered
        • Products Covered
      • Market Forecast Data
    • Percutaneous Thrombectomy Device Market
      • Market Definitions
        • Market Definitions
      • Market Forecast Data
        • Mechanical Thrombectomy
        • Aspiration Thrombectomy
    • Embolectomy Balloon Catheter Market
      • Market Definitions
        • Market Definitions
      • Market Forecast Data
    • Catheter-Directed Thrombolysis Device Market
      • Market Definitions
        • Market Definitions
      • Market Forecast Data
    • Inferior Vena Cava Filter Market
      • Market Definitions
        • Market Definitions
      • Market Forecast Data
    • Neurovascular Embolectomy Device Market
      • Market Definitions
        • Market Definitions
      • Market Forecast Data
    • Appendix
      • Abbreviations

Author(s): Ashish Bhupal, MBA

Ashish Bhupal is a manager within the Cardiovascular Medtech Insights team at DRG (Part of Clarivate), specializing in clot management, vascular access, aortic repair, heart valve, structural heart, interventional oncology, peripheral vascular, neurovascular, and transcatheter embolization and occlusion device markets. Ashish holds a Bachelor's in Biotechnology and an MBA in Biotechnology Management from Amity University, as well as a Six Sigma Green Belt certification from The British Standards Institution. Follow Ashish on Twitter: @Ashishb_DRG.


Related Reports

Clot Management Devices | Medtech 360 | Market Insights | Europe (Supplemental)

Note: this series will no longer be updated. For the latest developments in these markets, please refer to the Interventional Cardiology Device, Peripheral Vascular Device,...

View Details

Clot Management Devices | Medtech 360 | Market Insights | Europe

Note: this series will no longer be updated. For the latest developments in these markets, please refer to the Interventional Cardiology Device, Peripheral Vascular Device,...

View Details

Clot Management Devices | Medtech 360 | Market Insights | Japan

Note: this series will no longer be updated. For the latest developments in these markets, please refer to the Interventional Cardiology Device, Peripheral Vascular Device,...

View Details

Clot Management Devices | Medtech 360 | Market Insights | United States

Note: this series will no longer be updated. For the latest developments in these markets, please refer to the Interventional Cardiology Device, Peripheral Vascular Device,...

View Details